|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 44, 859-866, April 2003
Copyright © 2003 by Lipid Research, Inc.
Methods |
-hydroxylase activity by assay of the stable bile acid intermediate 7
-hydroxy-4-cholesten-3-one in peripheral blood
Metabolism Unit, Center for Metabolism and Endocrinology, Department of Medicine and Molecular Nutrition Unit, Center for Nutrition and Toxicology, NOVUM, Karolinska Institute at Huddinge University Hospital, S-141 86 Stockholm, Sweden
1 To whom correspondence should be addressed. e-mail: mats.rudling{at}cnt.ki.se
We describe an accurate method for monitoring the enzymatic activity of hepatic cholesterol 7
-hydroxylase (C7
OH; CYP7A1), the rate-limiting and major regulatory enzyme in the synthesis of bile acids. Assay of 7
-hydroxy-4-cholesten-3-one (C4), an intermediate in bile acid synthesis, revealed that the level of C4 in peripheral blood serum or plasma showed a strong correlation to the enzymatic activity of hepatic C7
OH, both at steady-state conditions (r = 0.929) as well as during the rapid changes that occur during the diurnal phases.
This assay should be of value in clarifying the regulation of bile acid synthesis in vivo in laboratory animals and humans since it allows for the monitoring of hepatic C7
OH activity using peripheral blood samples.
Abbreviations: C4, 7
-hydroxy-4-cholesten-3-one; C7
OH, cholesterol 7
-hydroxylase
Supplementary key words CYP7A1 cholic acid cholestyramine high performance liquid chromatography species
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Lenicek, M. Juklova, J. Zelenka, J. Kovar, M. Lukas, M. Bortlik, and L. Vitek Improved HPLC Analysis of Serum 7{alpha}-Hydroxycholest-4-en-3-one, a Marker of Bile Acid Malabsorption Clin. Chem., June 1, 2008; 54(6): 1087 - 1088. [Full Text] [PDF] |
||||
![]() |
A. Berkenstam, J. Kristensen, K. Mellstrom, B. Carlsson, J. Malm, S. Rehnmark, N. Garg, C. M. Andersson, M. Rudling, F. Sjoberg, et al. From the Cover: The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans PNAS, January 15, 2008; 105(2): 663 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Galman, M. Matasconi, L. Persson, P. Parini, B. Angelin, and M. Rudling Age-induced hypercholesterolemia in the rat relates to reduced elimination but not increased intestinal absorption of cholesterol Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E737 - E742. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Theuwissen and R. P. Mensink Simultaneous Intake of {beta}-Glucan and Plant Stanol Esters Affects Lipid Metabolism in Slightly Hypercholesterolemic Subjects J. Nutr., March 1, 2007; 137(3): 583 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Honda, K. Yamashita, M. Numazawa, T. Ikegami, M. Doy, Y. Matsuzaki, and H. Miyazaki Highly sensitive quantification of 7{alpha}-hydroxy-4-cholesten-3-one in human serum by LC-ESI-MS/MS J. Lipid Res., February 1, 2007; 48(2): 458 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Johansson, M. Rudling, T. S. Scanlan, T. Lundasen, P. Webb, J. Baxter, B. Angelin, and P. Parini Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice PNAS, July 19, 2005; 102(29): 10297 - 10302. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Brousseau, M. R. Diffenderfer, J. S. Millar, C. Nartsupha, B. F. Asztalos, F. K. Welty, M. L. Wolfe, M. Rudling, I. Bjorkhem, B. Angelin, et al. Effects of Cholesteryl Ester Transfer Protein Inhibition on High-Density Lipoprotein Subspecies, Apolipoprotein A-I Metabolism, and Fecal Sterol Excretion Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 1057 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Boekschoten, M. K. Hofman, R. Buytenhek, E. G. Schouten, H. M. G. Princen, and M. B. Katan Coffee Oil Consumption Increases Plasma Levels of 7{alpha}-Hydroxy-4-cholesten-3-one in Humans J. Nutr., April 1, 2005; 135(4): 785 - 789. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Matasconi, B. Angelin, and M. Rudling Pituitary control of lipoprotein and bile acid metabolism in male rats: growth hormone effects are not mediated by prolactin Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E114 - E119. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lind, M. Rudling, S. Ericsson, H. Olivecrona, M. Eriksson, B. Borgstrom, G. Eggertsen, L. Berglund, and B. Angelin Growth Hormone Induces Low-Density Lipoprotein Clearance but not Bile Acid Synthesis in Humans Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): 349 - 356. [Abstract] [Full Text] |
||||
![]() |
T. Lundasen, W. Liao, B. Angelin, and M. Rudling Leptin Induces the Hepatic High Density Lipoprotein Receptor Scavenger Receptor B Type I (SR-BI) but Not Cholesterol 7{alpha}-Hydroxylase (Cyp7a1) in Leptin-deficient (ob/ob) Mice J. Biol. Chem., October 31, 2003; 278(44): 43224 - 43228. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |